Argus Downgrades Campbell Soup (CPB) to Hold
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Argus downgraded Campbell Soup (NYSE: CPB) from Buy to Hold on a weaker near-term outlook.
"Although we have a favorable view of Campbell’s efforts to focus on healthier foods, we expect relatively slow growth in the Campbell Fresh division, which posted lower sales in fiscal 4Q16," the analyst said.
The firm is lowering FY17 EPS estimate from $3.24 to $3.02 and setting a preliminary estimate of $3.16 for FY18.
Shares of Campbell Soup closed at $55.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Cuts Teva Pharma (TEVA) to Neutral Amid Challenging Generic Environment
- JPMorgan Downgrades Endo International plc (ENDP) to Neutral
- UPDATE: SunTrust Robinson Humphrey Downgrades Health Care REIT (HCN) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!